Skip to main content
Top
Published in: Clinical & Experimental Metastasis 6/2010

01-08-2010 | Editorial Comment

Genomics of metastatic progression

Authors: Adriana Albini, József Tímár

Published in: Clinical & Experimental Metastasis | Issue 6/2010

Login to get access

Excerpt

Metastatic potential of transformed cells is the hallmark of malignancy and is the basis of pathological diagnosis of tumors. Characterization of the metastatic potential of cancer cells is still a hot topic in cancer research despite of a pletora of studies published in the past decade. Although these studies provided meaningful information on the basic alterations at expression levels, these data are frequently controversial. Controversies exist between cellular systems, preclinical models and clinicopathological studies. The data indicate that in vitro systems are dependent on the effects of the specific artificial conditions, that preclinical models are affected significantly by the „foreign” stroma signatures of the host and that the clinicopathological studies are greatly dependent on the histopathological specifics of the cancer. Furthermore, all these variabilities are further complicated by the specificities of the array platforms used throughout these studies. …
Metadata
Title
Genomics of metastatic progression
Authors
Adriana Albini
József Tímár
Publication date
01-08-2010
Publisher
Springer Netherlands
Published in
Clinical & Experimental Metastasis / Issue 6/2010
Print ISSN: 0262-0898
Electronic ISSN: 1573-7276
DOI
https://doi.org/10.1007/s10585-010-9348-6

Other articles of this Issue 6/2010

Clinical & Experimental Metastasis 6/2010 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine